Correspondence:
Yogen Saunthararajah, MD
Department of Translational Hematology and Oncology Research, Lerner
Research Institute, Cleveland Clinic,
9620 Carnegie Ave N building, NE6‐250, Cleveland, OH 44106, USA. E‐mail:
saunthy@ccf.org
Running title: Non-cytotoxic decitabine for refractory T-LGL
Keywords : decitabine, T-cell large granular lymphocytic
leukemia, frail patients, non-cytotoxic regimen